Chapter

Corporate Responsibility for Pharmaceutical Corporations

Klaus M. Leisinger

in The Responsible Corporation in a Global Economy

Published in print October 2011 | ISBN: 9780199592173
Published online January 2012 | e-ISBN: 9780191729058 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780199592173.003.0005
Corporate Responsibility for Pharmaceutical Corporations

Show Summary Details

Preview

This chapter considers the role and responsibilities of a responsible corporation from the perspective of a global pharmaceutical. Many examples are provided of how CSR process, practice, and perspective are inextricably interdependent and interwoven at two key levels of the institutional and the personal. The importance of how a corporation achieves its business objective of maximizing profits is discussed. The United Nations Global Compact (GC) as a frame of reference for corporate responsibility reflections is discussed, as well as its limitations. When talking about a responsible ‘corporation’, the significance of the personal level of the company's managers and employees is identified. Thus, the ethics of top managers is a key point that has further implications in understanding how moral norms, including corporate responsibility norms, are likely to be filled when they appear self‐evident to the agent expected to act within specific contexts.

Keywords: CSR; pharmaceutical company; ethics; UN Global Compact

Chapter.  8497 words.  Illustrated.

Subjects: Corporate Governance

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.